These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 2182331

  • 1. Variable effect of recombinant human granulocyte-macrophage colony-stimulating factor on bone marrow fibrosis in patients with myelodysplasia.
    Antin JH, Weinberg DS, Rosenthal DS.
    Exp Hematol; 1990 May; 18(4):266-70. PubMed ID: 2182331
    [Abstract] [Full Text] [Related]

  • 2. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor.
    Broxmeyer HE, Cooper S, Williams DE, Hangoc G, Gutterman JU, Vadhan-Raj S.
    Exp Hematol; 1988 Aug; 16(7):594-602. PubMed ID: 3260558
    [Abstract] [Full Text] [Related]

  • 3. Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) in bone marrow failure.
    Antin JH, Smith BR, Holmes W, David RN, Rosenthal S.
    Behring Inst Mitt; 1988 Aug; (83):149-53. PubMed ID: 3071331
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mechanism of synergy between granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in colony formation from human marrow cells in vitro.
    Hara H, Namiki M.
    Exp Hematol; 1989 Aug; 17(7):816-21. PubMed ID: 2473914
    [Abstract] [Full Text] [Related]

  • 7. Effects of CSFs in preleukemia.
    Greenberg PL, Negrin R, Nagler A.
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():121-6. PubMed ID: 1697191
    [Abstract] [Full Text] [Related]

  • 8. Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) shortens the period of neutropenia after autologous bone marrow transplantation in a primate model.
    Nienhuis AW, Donahue RE, Karlsson S, Clark SC, Agricola B, Antinoff N, Pierce JE, Turner P, Anderson WF, Nathan DG.
    J Clin Invest; 1987 Aug; 80(2):573-7. PubMed ID: 3301903
    [Abstract] [Full Text] [Related]

  • 9. Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors.
    Ottmann OG, Abboud M, Welte K, Souza LM, Pelus LM.
    Exp Hematol; 1989 Feb; 17(2):191-7. PubMed ID: 2463933
    [Abstract] [Full Text] [Related]

  • 10. The use of haemopoietic growth factors in the treatment of myelodysplastic syndromes.
    Greenberg PL, Negrin R, Nagler A.
    Cancer Surv; 1990 Feb; 9(1):199-212. PubMed ID: 2276114
    [Abstract] [Full Text] [Related]

  • 11. Enhanced myelopoiesis in long-term cultures of human bone marrow pretreated with recombinant granulocyte-macrophage colony-stimulating factor.
    Haas R, Ogniben E, Kiesel S, Hohaus S, Baumann M, Körbling M, Dörken B, Hunstein W.
    Exp Hematol; 1989 Mar; 17(3):235-9. PubMed ID: 2645156
    [Abstract] [Full Text] [Related]

  • 12. A phase I study of therapy with recombinant granulocyte-macrophage colony-stimulating factor administered by IV bolus or continuous infusion.
    Rifkin RM, Hersh EM, Salmon SE.
    Behring Inst Mitt; 1988 Aug; (83):125-33. PubMed ID: 3071327
    [Abstract] [Full Text] [Related]

  • 13. Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies.
    Vose JM, Bierman PJ, Ruby E, Reed EC, Bishop MR, Tarantolo S, Kessinger A, Armitage JO.
    Bone Marrow Transplant; 1996 Jun; 17(6):951-6. PubMed ID: 8807099
    [Abstract] [Full Text] [Related]

  • 14. Effects of granulocyte-macrophage colony-stimulating factor in iatrogenic myelosuppression, bone marrow failure, and regulation of host defense.
    Gutterman J, Vadhan-Raj S, Logothetis C, Anaissle E, Estey E, Talpaz M, Kurzrock R.
    Semin Hematol; 1990 Jul; 27(3 Suppl 3):15-24. PubMed ID: 2198660
    [Abstract] [Full Text] [Related]

  • 15. Phase I/II study with GM-CSF in patients with myelodysplastic syndromes.
    Hoelzer D, Ganser A, Greher J, Völkers B, Walther F.
    Behring Inst Mitt; 1988 Aug; (83):134-8. PubMed ID: 3071328
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Indomethacin augments granulocyte-macrophage colony-stimulating factor-induced hematopoiesis following 5-FU treatment.
    O'Reilly M, Gamelli RL.
    Exp Hematol; 1990 Oct; 18(9):974-8. PubMed ID: 2204540
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome with excess blasts.
    Herrmann F, Lindemann A, Klein H, Lübbert M, Schulz G, Mertelsmann R.
    Leukemia; 1989 May; 3(5):335-8. PubMed ID: 2654495
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.